Babylon Announces Date of Third Quarter 2021 Financial Results

PALO ALTO, Calif. & LONDON--(BUSINESS WIRE)-- Babylon Holdings Limited (NYSE: BBLN or the “Company”) will host a conference call on Friday, November 12, 2021, at 8:00 AM Eastern Time to review the Company’s fiscal third quarter 2021 financial results. A press release announcing the fiscal third quarter results will be issued on Friday, November 12, 2021, before the market opens.

To participate in the Company’s live conference call and webcast, please dial (877) 407-7994 for U.S. participants, or +1 (215) 268-9868 for international participants, or visit the “News & Events” section of https://ir.babylonhealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

About Babylon

Babylon is a world leading, digital-first, value-based care company whose mission is to make high-quality healthcare accessible and affordable for everyone on Earth.

Babylon is re-engineering healthcare, shifting the focus from sick care to preventative healthcare so that patients experience better health, and reduced costs. This is achieved by leveraging a highly scalable, digital-first platform combined with high quality, virtual clinical operations to provide integrated, personalized healthcare. We endeavor to support patients’ health needs, all from their devices, with the aim to promote longer and healthier lives. When sick, Babylon provides assistance to navigate the health system, connecting patients digitally to the right clinician 24/7, at no additional cost.

Founded in 2013, we have since delivered millions of clinical consultations and AI interactions, with c.2m clinical consultations and c.3.9m AI interactions in 2020 alone. We work with governments, health providers and insurers across the globe, and support healthcare facilities from small local practices to large hospitals. For more information, please visit www.babylonhealth.com/us.

Media
Adam Davison
press@babylonhealth.com

Investors
Kathy Kress
investors@babylonhealth.com

Source: Babylon Holdings Limited